Linda Palczuk is Director of AVADEL PHARMACEUTICALS PLC. Currently has a direct ownership of 62,900 shares of AVDL, which is worth approximately $668,627. The most recent transaction as insider was on Dec 24, 2024, when has been sold 3,500 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62.9K
0.79% 3M change
20.04% 12M change
Total Value Held $668,627

Linda Palczuk Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 24 2024
SELL
Bona fide gift
-
3,500 Reduced 5.27%
62,900 Ordinary Shares
Dec 06 2024
BUY
Open market or private purchase
$30,570 $10.19 p/Share
3,000 Added 4.32%
66,400 Ordinary Shares
Jul 30 2024
BUY
Grant, award, or other acquisition
-
11,000 Added 14.78%
63,400 Ordinary Shares
May 09 2023
BUY
Open market or private purchase
$36,900 $14.76 p/Share
2,500 Added 4.55%
52,400 ADSs
Dec 23 2022
BUY
Open market or private purchase
$14,400 $7.2 p/Share
2,000 Added 3.85%
49,900 ADSs
May 27 2022
BUY
Open market or private purchase
$16,000 $1.6 p/Share
10,000 Added 17.27%
47,900 ADSs
LP

Linda Palczuk

Director
Dublin 2, L2

Track Institutional and Insider Activities on AVDL

Follow AVADEL PHARMACEUTICALS PLC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVDL shares.

Notify only if

Insider Trading

Get notified when an Avadel Pharmaceuticals PLC insider buys or sells AVDL shares.

Notify only if

News

Receive news related to AVADEL PHARMACEUTICALS PLC

Track Activities on AVDL